Lv2
138 积分 2023-01-29 加入
Combination Therapy for EGFR -Mutated Lung Cancer
8小时前
待确认
Cancer-Induced Fatigue and Skeletal Muscle Wasting: The Role of Exercise
1个月前
已完结
Abstract 6754: Clinical characteristics, real-world treatment patterns, and clinical outcomes among patients with previously treated metastatic or unresectable EGFR-mutated non-small cell lung cancer in the United States
1个月前
已关闭
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
4个月前
已完结
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
9个月前
已完结
Progress in the treatment of malignant ascites
1年前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
1年前
已完结
Abstract CT075: Updated overall survival outcomes from a randomized, double-blind phase III study of sintilimab versus placebo in combination with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma (ORIENT-15)
1年前
已关闭
Successful Osimertinib Rechallenge After Relapse Following Adjuvant Osimertinib: A Case Report
1年前
已完结
Abstract 6754: Clinical characteristics, real-world treatment patterns, and clinical outcomes among patients with previously treated metastatic or unresectable EGFR-mutated non-small cell lung cancer in the United States
1年前
已关闭
Assessing the impact of nonspecific binding on oligonucleotide bioanalysis
2年前
已采纳
Single-cell RNA-Seq of human esophageal epithelium in homeostasis and allergic inflammation
2年前
已采纳
Unfolding the popularity of video conferencing apps – A privacy calculus perspective
2年前
已采纳
Concurrent chemoradiotherapy improves prognosis and quality of life of patients with metastatic and recurrent hepatocellular carcinoma
2年前
已采纳
皖公网安备34019202002308
